Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


Diet & Health : Cancer Last Updated: Apr 20, 2011 - 9:38:09 AM


Low Serum vitamin D level means high risk of prostate cancer death
By David Liu
Mar 2, 2009 - 3:41:50 PM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   

March 1, 2009 (foodconsumer.org) -- A new study published online January 20, 2009 in the British Journal of Cancer suggests that low vitamin D levels in the blood could increase risk of death from prostate cancer.

The study led by Dr. T. E. Robsahm at the Cancer Registry of Norway, Institute of Population-based Cancer Research and colleagues found prostate cancer patients who had medium or high levels of vitamin D in their blood were much less likely to die from the disease.

Vitamin D deficiency has been linked to high risk of at least 17 different types of cancers, according to the Vitamin D Council. And many studies have suggested that increasing serum levels of vitamin D can reduce risk of developing cancer.

For the current study, Robsahm and colleagues followed for an average of 44 months 160 patients whose vitamin D levels were tested prior to treatments. The serum level of vitamin D, namely 25(OH)D, was classified as low (less than 50 nmol/L), medium (50 to 80 nmol/L) or high (higher than 80 nmol/L).

During the follow-up, 52 patients died from prostate cancer. The researchers found serum 25(OH)D at medium or high levels were significantly associated with better prognosis. Men with medium levels were 67 percent less likely and those with high levels were 84 percent less likely to die from prostate cancer than those with the low level.

The study suggests that boosting serum levels of vitamin D by increasing exposure to sunlight or intake of dietary vitamin D may reduce the risk of prostate cancer death or prevent the disease in the first place.

The National Cancer Institute estimated that prostate cancer was diagnosed in 186,320 men in 2008 in the United States and the disease killed about 28,660 men in the same year.






© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.